Joinn Laboratories(China)Co.,Ltd.
603127
Clasificación en acciones
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Precio por acción
$6.82
Capitalización bursátil
$4.30B
Cambio (1 día)
-6.30%
Cambio (1 año)
48.79%
País
CN
Comercio Joinn Laboratories(China)Co.,Ltd. (603127)
Categoría
Healthcare
Ratio P/S de Joinn Laboratories(China)Co.,Ltd. (603127)
Ratio P/S al October 2026 TTM: 16.96
Según los informes financieros más recientes y el precio de las acciones de Joinn Laboratories(China)Co.,Ltd., el ratio P/S actual (TTM) es 16.96. Al final de 2024, el ratio P/S era 6.10.
Historial del ratio P/S de Joinn Laboratories(China)Co.,Ltd. desde 2012 hasta 2026
Ratio P/S al final de cada año
| Año | Ratio P/S | Cambiar |
|---|---|---|
| 2026 (TTM) | 16.96 | 7.83% |
| 2025 | 15.73 | 157.67% |
| 2024 | 6.10 | -15.66% |
| 2023 | 7.24 | -47.54% |
| 2022 | 13.80 | -50.84% |
| 2021 | 28.06 | 29.16% |
| 2020 | 21.73 | 49.50% |
| 2019 | 14.53 | 9.31% |
| 2018 | 13.30 | 3.24% |
| 2017 | 12.88 | 181.31% |
| 2016 | 4.58 | -14.49% |
| 2015 | 5.35 | -10.22% |
| 2014 | 5.96 | -23.01% |
| 2013 | 7.75 | -30.15% |
| 2012 | 11.09 | 0.00% |
Ratio P/S de empresas similares o competidoras
| Empresa | Ratio P/S | Diferencia del ratio P/S | País |
|---|---|---|---|
| 5.29 | -68.79% |
US
|
|
| 6.43 | -62.11% |
US
|
|
| 21.32 | 25.68% |
US
|
|
| 6.53 | -61.51% |
CN
|
|
| 6.80 | -59.91% |
US
|
